<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of burn wound pain and itching</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of burn wound pain and itching</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Management of burn wound pain and itching</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shelley Wiechman, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul I Bhalla, MBChB, FRCA, FFPMRCA</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marc G Jeschke, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 22, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H10926413"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Burn wounds can be extremely painful and should be treated aggressively. Pain management, which includes pharmacologic and nonpharmacologic approaches, is a central component of the complex issues involved in treating patients with burns. Management of anxiety is also important given that high levels of anxiety can increase the perception of pain. Poor pain and anxiety management can contribute to delayed wound healing [<a href="#rid1">1</a>]. Burn pain is also among the most common causes of distress during the first year after discharge [<a href="#rid2">2,3</a>]. </p><p>Inadequate burn pain management still exists during both the acute and rehabilitation phases of care [<a href="#rid4">4,5</a>]. The risks of under-medicating burn pain on long-term negative outcomes are well documented [<a href="#rid6">6,7</a>]. Unfortunately, burn pain management is frequently based upon tradition, personal bias, and/or institutional preference rather than evidence-based protocols that report reduced pain and anxiety with their use [<a href="#rid8">8,9</a>]. To address this, the American Burn Association conducted a systematic review and gathered experts in the field to establish evidence-based recommendations for the management of burn pain, which are included in this review [<a href="#rid10">10</a>].</p><p>An overview of pharmacologic and nonpharmacologic options for the management of burn pain is reviewed here. Emergency care and local management of burns and pain are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults"</a> and  <a class="medical medical_review" href="/z/d/html/6567.html" rel="external">"Moderate and severe thermal burns in children: Emergency management"</a> and  <a class="medical medical_review" href="/z/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care"</a> and  <a class="medical medical_review" href="/z/d/html/16505.html" rel="external">"Paradigm-based treatment approaches for management of burn pain"</a>.)</p><p class="headingAnchor" id="H10927394"><span class="h1">CHARACTERISTICS OF BURN PAIN</span><span class="headingEndMark"> — </span>Burn wounds are often painful at least initially [<a href="#rid11">11</a>]. The degree of pain varies depending upon the depth of the burn wound  (<a class="graphic graphic_figure graphicRef73309" href="/z/d/graphic/73309.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/z/d/html/819.html" rel="external">"Assessment and classification of burn injury"</a>.):</p><p class="bulletIndent1"><span class="glyph">●</span>Superficial partial-thickness burns result in hyperalgesia and mild-to-moderate pain. They are the most painful burns immediately following the injury. These burns damage only the outer layers of the skin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Moderate partial-thickness burns are associated with marked hyperalgesia and produce moderate-to-severe pain. Burns at this depth injure and/or inflame sensory receptors in the dermis. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Deep partial-thickness to full-thickness burns are typically characterized by an absence of pain. Hyperalgesia to cutaneous stimulation is uncommon. Acute pain is typically minimal but can be variable and is universally present with respect to the transition zone between burned and unburned skin. The dermis is completely destroyed, including its sensory and vascular structures. There is little to no response to sharp stimuli, yet patients complain of a deep aching pain related to the inflammatory response.</p><p></p><p>Burn wound pain can be unpredictable due to the complex interaction of anatomic, physiologic, psychosocial, and premorbid behavior issues. Burn patients typically report pain as being severe or excruciating despite receiving opioid analgesics. </p><p>Burn wound pain varies greatly from patient to patient, also showing substantial fluctuation over the course of hospitalization. (See  <a class="medical medical_review" href="/z/d/html/16505.html" rel="external">"Paradigm-based treatment approaches for management of burn pain", section on 'Burn pain paradigm'</a>.)</p><p class="headingAnchor" id="H11800749"><span class="h1">BURN PAIN ASSESSMENT TECHNIQUES</span><span class="headingEndMark"> — </span>Pain assessment tools are essential to determine the nature and severity of pain, the response to any pain management interventions, and the impact on function. Tools must be simple to use, easily reproducible (with high inter- and intrarater consistency), and simple to record. Although one-dimensional tools such as a numerical rating scale (0 to 10) are the most commonly used, an ideal pain assessment tool would be able to assess the complex, multidimensional nature of the subjective pain experience. Burn pain assessment should be done repeatedly throughout the day to account for all phases of care [<a href="#rid10">10</a>]. Pain assessment should be protocolized and documented in the electronic medical record. Most importantly, action must be taken in response to pain assessment data [<a href="#rid12">12</a>]. A variety of pain measurement tools have been used with adult and pediatric burn patients. However, there are no randomized trials that have identified an optimal assessment technique for burn patients. The key is to choose an instrument and use it consistently. The most common tools used for adults and children with burn pain include verbal adjective scales, numeric written or visual analog scales, pain assessment in dementia scales, FACES, and FLACC (Face, Legs, Activity, Cry, Consolability) [<a href="#rid11">11,13-17</a>]. </p><p class="headingAnchor" id="H11800756"><span class="h2">Adults</span><span class="headingEndMark"> — </span>A common tool for assessing postburn pain in adults is the categorical verbal rating scale, which allows a patient to describe the severity of pain in words, such as "none, mild, moderate, or severe." An alternative to the verbal description of pain is the numeric rating scale, which allows a patient to describe the pain on a scale of increasing severity, typically from 0 to 10  (<a class="graphic graphic_figure graphicRef72905" href="/z/d/graphic/72905.html" rel="external">figure 2</a>) [<a href="#rid15">15</a>]. The numeric scale is administered to the patient verbally or written as a visual analog scale  (<a class="graphic graphic_figure graphicRef62346" href="/z/d/graphic/62346.html" rel="external">figure 3</a>). Pain assessment can be challenging in the burned and patients with dementia. The Pain Assessment in Advanced Dementia Scale, an observational scoring instrument, is a simple-to-administer, valid, and reliable instrument  (<a class="graphic graphic_table graphicRef59509" href="/z/d/graphic/59509.html" rel="external">table 1</a>) [<a href="#rid17">17</a>]. The Critical-Care Pain Observation Tool is a behavioral tool that has been validated and can be used for nonresponsive patients in the intensive care unit [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/z/d/html/2888.html" rel="external">"Pain control in the critically ill adult patient", section on 'Goals of pain control'</a>.)</p><p class="headingAnchor" id="H11800763"><span class="h2">Children</span><span class="headingEndMark"> — </span>The measurement of pain in children is more complex than it is for adults, especially for preverbal children. Typical physiologic indicators, such as heart rate, respiratory rate, and blood pressure are unreliable in measuring a child's pain since all are affected by a variety of stressors related to the burn injury [<a href="#rid11">11,19</a>]. (See  <a class="medical medical_review" href="/z/d/html/6254.html" rel="external">"Pain in children: Approach to pain assessment and overview of management principles", section on 'Severity assessment'</a>.)</p><p>Behavior scales have been devised to measure pain by providing standardized instructions and guidelines for observing behaviors thought to be specific to pain. Facial expression may be the most consistent infant indicator of pain. Observational scales have been developed that are multidimensional and include length of cry, facial expressions, and behavioral states [<a href="#rid3">3</a>]. These scales are easier to use and allow an observer to assess pain as either present or absent without further quantification. The FLACC (Faces, Legs, Activity, Cry, Consolability scale) is the most widely used observer rating scale in preverbal children  (<a class="graphic graphic_table graphicRef81819" href="/z/d/graphic/81819.html" rel="external">table 2</a>) [<a href="#rid13">13,20</a>]. In one of the few studies to evaluate the FLACC, it was reported that nurses tended to underestimate mild and severe pain and that nurses with less experience had higher rates of accuracy [<a href="#rid21">21</a>].</p><p>Simple self-report pain scales can be used with preschool children. There is no evidence that any one of these scales is more reliable than the other; hence, it is best to select one that the evaluator prefers, and it should be used consistently. When self-report scales are used in conjunction with observational scales, a practitioner may develop a better appreciation of the intensity of the child's response to burn pain and the effectiveness of pain management. The Wong-Baker FACES Pain Scale is designed for children three years and older  (<a class="graphic graphic_figure graphicRef51021" href="/z/d/graphic/51021.html" rel="external">figure 4</a>) [<a href="#rid14">14</a>]. This pain scale uses drawings of faces<sup> </sup>displaying varying degrees of pain and discomfort. Each face communicates a level of pain intensity, and the child is asked to choose the face that most accurately describes their pain level. </p><p class="headingAnchor" id="H11800898"><span class="h1">PHARMACOLOGIC TREATMENT OPTIONS</span><span class="headingEndMark"> — </span>Pharmacologic agents used to treat burn pain include opioid analgesics, nonopioid analgesics, anxiolytics, and anesthetics. The type of medication used is determined by the severity of pain, the anticipated duration of pain, and intravenous (IV) access. These medications have variable durations of action, particularly in burn patients, and should be titrated to meet the needs of the patient in each clinical setting [<a href="#rid22">22</a>]. Nonopioid agents are at least as effective as opioids for many types of acute pain [<a href="#rid23">23</a>]. However, the necessity for wound care and dressing change procedures means pharmacologic sedation and analgesia are almost essential aspects of care in burn centers in the United States, particularly in children. One survey reported high-use frequencies for opioids (100 percent), benzodiazepines (91 percent), <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> (87 percent), <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> (57 percent), and <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> (48 percent) during pediatric burn dressing change [<a href="#rid24">24</a>].</p><p>Baseline preventive management of pain from burn injury must target the constant "background pain" associated with burn wounds. Pharmacologic techniques should include near-constant plasma levels of nonopioid analgesics through regularly scheduled administration of <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> and nonsteroidal anti-inflammatory agents (NSAIDs). Opioids should be initiated as immediate release, as needed, in the lowest effective dose to minimize risks [<a href="#rid23">23</a>]. Long-acting oral opioids (eg, <a class="drug drug_general" data-topicid="9623" href="/z/d/drug information/9623.html" rel="external">methadone</a>) have been used for the management of severe background burn wound pain. However, they are associated with higher risks of overdose, should only be considered in patients who have received maximal doses of immediate-release opioids daily for at least a week [<a href="#rid23">23</a>], and should only be prescribed by those familiar with their use and in a closely monitored environment. (See  <a class="medical medical_review" href="/z/d/html/16505.html" rel="external">"Paradigm-based treatment approaches for management of burn pain", section on 'Background pain'</a> and  <a class="medical medical_review" href="/z/d/html/108806.html" rel="external">"Management of acute pain in opioid naïve adults in the ambulatory setting"</a>.)</p><p>Managing anxiety is an important part of pain management, as anxiety and pain act as risk factors for each other. Benzodiazepines may have a role in patients with significant procedural anxiety that contributes to their pain experience. However, benzodiazepines should be avoided in patients who are experiencing delirium. (See  <a class="medical medical_review" href="/z/d/html/16851.html" rel="external">"Acute procedural anxiety and specific phobia of clinical procedures in adults: Treatment overview", section on 'Benzodiazepines as first-line medication'</a>.)</p><p>Because severe burn injury results in physiologic changes that may alter the pharmacokinetic and pharmacodynamic response to drugs in inconsistent ways, deviation from the usual doses may be necessary to avoid toxicity or decreased efficacy [<a href="#rid25">25</a>]. The tables linked to this topic provide dosages of opioids and nonopioid analgesias as recommended for patients without serious pathophysiologic and metabolic changes without altered drug clearance. These dosages serve as a reference point for administering pharmacologic agents to burned patients. Medications may be more potent or less potent and have a prolonged or shortened effect in the burn patient, depending only somewhat reliably on either the drug or patient factors. Monitoring of the airway, breathing, and circulation is necessary, particularly when intravenous drugs are administered. (See  <a class="medical medical_review" href="/z/d/html/818.html" rel="external">"Hypermetabolic response to moderate-to-severe burn injury and management"</a>.)</p><p class="headingAnchor" id="H11801092"><span class="h2">Opioid analgesics</span><span class="headingEndMark"> — </span>Opioid analgesics are used as a first-line treatment for moderate-to-severe acute pain and, despite a lack of evidence that they are any more effective than nonopioid analgesics [<a href="#rid10">10,26</a>], they have an important role for managing acute pain related to severe burns pain as part of a multimodal analgesic strategy. Opioid therapy also provides a dose-dependent degree of sedation important during burn wound care procedures  (<a class="graphic graphic_table graphicRef79667" href="/z/d/graphic/79667.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef79047" href="/z/d/graphic/79047.html" rel="external">table 4</a>) [<a href="#rid3">3</a>]. A review of intravenous opioid analgesia for adults and children is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/6254.html" rel="external">"Pain in children: Approach to pain assessment and overview of management principles", section on 'Opioids'</a> and  <a class="medical medical_review" href="/z/d/html/2888.html" rel="external">"Pain control in the critically ill adult patient"</a> and  <a class="medical medical_review" href="/z/d/html/139217.html" rel="external">"Procedural sedation in adults in the emergency department: Medication selection, dosing, and discharge criteria", section on 'Medications'</a> and  <a class="medical medical_review" href="/z/d/html/108806.html" rel="external">"Management of acute pain in opioid naïve adults in the ambulatory setting"</a>.)</p><p>Opioids can be administered intravenously, orally, and transnasally depending on IV access, gastrointestinal function, and the patient's ability to cooperate. For severe pain, the optimal route of administration is IV, which provides faster pain relief and can be effectively titrated to meet the individual needs of the patient. </p><p>Patient-controlled analgesia (PCA) with IV opioids provides the burn patient a safe and efficient method of achieving more flexible analgesia, provided the patient is alert and competent enough to use the device  (<a class="graphic graphic_table graphicRef101248" href="/z/d/graphic/101248.html" rel="external">table 5</a>) [<a href="#rid27">27</a>]. A common limitation of PCA use is that patients are unable to press the button to deliver a dose while asleep and may complain of waking up in pain after sleeping for more than a few hours. Some centers allow for a continuous background infusion of low-dose opioid via the PCA device, but this increases the risk of oversedation and symptomatic opioid overdose. Studies comparing PCA opioid use with other routes of administration in the burn population have shown positive, but limited, benefits [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/134254.html" rel="external">"Use of opioids for postoperative pain control", section on 'IV opioids'</a>.)</p><p>Oral or gastrointestinal administration of immediate-release opioids via an enteral tube provides potent pain relief with a relatively rapid onset (5 to 30 minutes depending on the drug used) and a duration of action up to several hours and requires minimal monitoring. Buccal, sublingual, or intranasal transmucosal administration can be helpful for performing burn dressing changes, particularly in children [<a href="#rid29">29,30</a>]. A systematic review reported transmucosal administration to be at least equivalent in analgesic effect to oral opioids in both adults and children [<a href="#rid31">31</a>].</p><p>Intramuscular opioid administration is <strong>not</strong> recommended for use in burn patients. The injections are painful, they need to be repeated frequently, and the absorption is variable due to compartmental fluid shifts. </p><p class="headingAnchor" id="H11801099"><span class="h2">Nonopioid analgesics</span><span class="headingEndMark"> — </span>Nonopioid analgesics can be as effective as opioids for many types of acute pain, especially mild-to-moderate pain, and should always be used in conjunction with opioid therapy. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>NSAIDs</strong> – Oral NSAIDs and <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> have a long-established safety profile and are suited to manage mild-to-moderate pain, particularly in the outpatient setting  (<a class="graphic graphic_table graphicRef70067" href="/z/d/graphic/70067.html" rel="external">table 6</a>) [<a href="#rid32">32</a>]. These drugs exhibit a ceiling effect in their dose-response relationship, rendering them unsuitable as single agents for the treatment of severe burn pain. However, they are likely to have an additive effect when combined with other analgesic modalities, including opioids, to treat more severe pain. The use of NSAIDS in critically ill patients with burns is limited by potential adverse effects such as acute kidney injury, reduction in platelet activity, and gastrointestinal bleeding [<a href="#rid33">33</a>]. The mechanism of action and therapeutic use of NSAIDs is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7993.html" rel="external">"NSAIDs: Therapeutic use and variability of response in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gabapentinoids</strong> – The gabapentinoid agents, <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">gabapentin</a> and <a class="drug drug_general" data-topicid="9473" href="/z/d/drug information/9473.html" rel="external">pregabalin</a>, may have a role in acute neuropathic pain, but evidence is conflicting in the burns population [<a href="#rid33">33</a>]. A randomized trial showed no reduction in the use of opioids or self-reported pain scores with the use of gabapentin versus placebo in the acute burn injury period [<a href="#rid34">34</a>]. However, another trial using pregabalin reported a significant reduction in neuropathic pain elements, such as "hot pain," "sharp pain" and itch, as well as procedural pain when used over a four-week period following burn injury of 5 percent or more [<a href="#rid35">35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">Dexmedetomidine</a> – Dexmedetomidine is an alpha -2 adrenergic receptor agonist used to provide short-term, effective analgesia and sedation that may be helpful for limited burn debridement and/or dressing changes in adults and children. Dexmedetomidine provides sedation, anxiolysis, and analgesia for burned children, with less respiratory depression than other sedatives [<a href="#rid36">36,37</a>]. However, a meta-analysis of four studies showed better sedation but no analgesic benefit of using dexmedetomidine for procedural care in adult and pediatric burns patients [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">Ketamine</a> – Ketamine is an anesthetic agent that may be useful as an adjunctive treatment for acute pain when used in subanesthetic doses in hospitalized inpatients. Its benefit is mostly seen in patients with high levels of nociception and central sensitization and in opioid-tolerant patients [<a href="#rid39">39</a>]. Ketamine has a long history of use for procedural wound care pain in burn-injured patients. Studies suggest it is both an effective and safe analgesic in adult and pediatric patients with burns [<a href="#rid40">40,41</a>]. Ketamine dosing to achieve moderate sedation in burned patients is similar to that used in other procedural pain settings and is typically limited to short procedures (5 to 15 minutes) due to its pharmacokinetics following bolus dosing. Burn care procedures that require deep sedation or general anesthesia (eg, longer procedures or those requiring absolute immobility) are better managed with either regional anesthesia or with more potent sedative/hypnotic or volatile anesthetic agents. (See  <a class="medical medical_review" href="/z/d/html/264.html" rel="external">"Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications"</a> and  <a class="medical medical_review" href="/z/d/html/82857.html" rel="external">"Pediatric procedural sedation: Pharmacologic agents"</a>.)</p><p></p><p class="headingAnchor" id="H11801106"><span class="h2">Anxiolytics</span><span class="headingEndMark"> — </span>Anxiety is a common consequence of burns, due to the need for aggressive surgical treatment and debridement of the wounds, and the persistent and repetitive qualities of background and procedural burn pain. The practice of using anxiolytic drugs in combination with opioid analgesics has become more widespread in burn centers in the past three decades [<a href="#rid42">42</a>]. This practice may be useful in premedicating patients for wound care, due to the anticipatory anxiety experienced by these patients prior to and during such procedures, but nonpharmacologic treatments for anxiety should be considered as essential first-line components to the overall approach. (See  <a class="medical medical_review" href="/z/d/html/94580.html" rel="external">"Anesthesia for patients with acute burn injuries"</a> and  <a class="medical medical_review" href="/z/d/html/16618.html" rel="external">"Acute procedural anxiety in adults: Epidemiology, clinical features, assessment, and diagnosis"</a>.)</p><p>Benzodiazepine therapy improves postprocedure pain scores in certain burn patients. A trial that randomly assigned 79 burn patients to receive <a class="drug drug_general" data-topicid="9573" href="/z/d/drug information/9573.html" rel="external">lorazepam</a> or placebo in addition to their standard opioid analgesics only found a difference between groups in patients with high baseline pain in whom lorazepam significantly reduced visual analog scale pain score ratings [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/z/d/html/16851.html" rel="external">"Acute procedural anxiety and specific phobia of clinical procedures in adults: Treatment overview", section on 'Benzodiazepines as first-line medication'</a>.)</p><p>Although benzodiazepines are accepted as an efficacious tool for procedural and background anxiety, they are also associated with sedation, dependence, and addiction when used long term even at recommended doses. In 2016 the US Food and Drug Administration issued a strong warning about the use of benzodiazepines with opioids and the risk of unintentional overdose [<a href="#rid44">44</a>]. Caution should be used when prescribing these drugs, and it is not recommended to use these together in the outpatient setting. </p><p>The antihistamine agent <a class="drug drug_general" data-topicid="8544" href="/z/d/drug information/8544.html" rel="external">hydroxyzine</a> is commonly used for perioperative sedation, but evidence for its use, particularly in procedural sedation, is lacking. A recent study found the combination of hydroxyzine and clown therapy was better than placebo or clown therapy alone in reducing perioperative anxiety in children [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H11801113"><span class="h2">Anesthetics</span><span class="headingEndMark"> — </span>A variety of anesthetic techniques can be used (eg, general anesthesia, neuraxial anesthesia, peripheral nerve block) for managing burn pain in various clinical settings. The details of administration of anesthesia are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/94580.html" rel="external">"Anesthesia for patients with acute burn injuries"</a>.)</p><p class="headingAnchor" id="H38726099"><span class="h3">General anesthesia or deep sedation</span><span class="headingEndMark"> — </span>A general anesthetic or deep sedation provides relief of relatively brief, intense pain that would be experienced during a procedure, such as extensive wound debridement or dressing changes that occur outside of the operating room. While the risks of complications following a general anesthetic are low in healthy individuals, burn patients have metabolic, physiologic, and thermoregulatory abnormalities as well as possible inhalation injuries that are associated with increased risk of complications of perioperative hypothermia, hypoxemia, and abnormal responses to some anesthetic agents and to both depolarizing and nondepolarizing muscle relaxants [<a href="#rid46">46</a>]. As an example, <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> clearance and volume of distribution are increased in patients with major burns and may require larger bolus and/or infusion doses to maintain therapeutic plasma drug concentrations [<a href="#rid47">47</a>]. </p><p>Inhaled <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">nitrous oxide</a> is an anesthetic agent that can be safely administered and provides effective analgesia without loss of consciousness (ie, moderate sedation) for moderately painful procedures. It can be used for the treatment of burn pain, typically as a 50 percent mixture in 50 percent oxygen, and self-administered by an awake, cooperative, and spontaneously breathing patient via a mouthpiece or mask [<a href="#rid32">32,48</a>]. </p><p>Full anesthetic care capabilities have been extended outside the operating room into specialized, high-volume burn center intensive care units [<a href="#rid49">49,50</a>]. Drugs, such as intravenously administered <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> or <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">remifentanil</a> and inhaled <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">sevoflurane</a>, with rapid onset and short duration of action, rapid recovery, and few side effects can facilitate burn care and pain management in the patient's hospital location without transporting the patient to the operating room. The occasional provision of brief, dense analgesia/anesthesia (eg, general anesthesia or deep sedation) should be administered in a comprehensively monitored setting by medical professionals specifically trained to provide the service. When administered in a controlled environment, general anesthesia or deep sedation is safe and efficient, both in terms of allowing wound care (eg, debridement of facial burns in children) to proceed rapidly and in terms of cost-effective use of the operating room only for true surgical burn care procedures.</p><p class="headingAnchor" id="H38726107"><span class="h3">Peripheral nerve block</span><span class="headingEndMark"> — </span>Regional anesthesia is achieved by injecting a local anesthetic agent (eg, <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>, <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">ropivacaine</a>) near a nerve to block the sensory stimulation from the area innervated by the nerve, with one review supporting its use in managing procedural burn pain in addition to multimodal pain treatment [<a href="#rid51">51</a>]. These are particularly useful for procedures and burn pain relief involving the extremities [<a href="#rid52">52</a>]. The most common nerve groups accessible for a nerve block include the brachial plexus (interscalene block, infraclavicular block, axillary block), the sciatic nerve, and the femoral nerve. Other nerve blocks include the fascia iliaca compartment blockade (FICB) and lateral femoral cutaneous nerve block, which can be used for lower extremity analgesia following skin graft harvesting [<a href="#rid53">53-55</a>]. A review of regional anesthesia blocks for acute burn care is available and includes illustrative graphic descriptions of regional anatomy, as well as indications, contraindications, and potential complications [<a href="#rid56">56</a>]. (See  <a class="medical medical_review" href="/z/d/html/397.html" rel="external">"Overview of peripheral nerve blocks"</a>.)</p><p class="headingAnchor" id="H38726115"><span class="h3">Neuraxial anesthesia</span><span class="headingEndMark"> — </span>Neuraxial anesthesia is the administration of an anesthetic agent (eg, <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>, <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>) and/or opioid analgesics via a spinal or epidural catheter with the goal of providing background, procedural, and postoperative pain relief. This procedure has only been anecdotally used in burn patients [<a href="#rid57">57</a>]. A major drawback to the use of neuraxial anesthesia is the potential colonization of the indwelling catheter, particularly if inserted through burned skin, and the associated risks of meningitis and epidural abscess formation [<a href="#rid58">58</a>]. </p><p class="headingAnchor" id="H1085423102"><span class="h1">TREATMENT OF PRURITUS</span><span class="headingEndMark"> — </span>Severe pruritus occurs in as many as 87 percent of adult and 100 percent of pediatric burn patients during the healing process [<a href="#rid59">59-61</a>]. Pruritus tends to present early during wound healing and continues well after reepithelialization and scar maturation and can significantly impact quality of life [<a href="#rid62">62,63</a>]. Some studies have shown pruritus to persist for up to 10 years post-burn in almost one-half of burn patients [<a href="#rid64">64</a>]. An overview of the treatment of burn scar complications often causing pruritus and pruritus in general are presented elsewhere. (See  <a class="medical medical_review" href="/z/d/html/95111.html" rel="external">"Hypertrophic scarring and keloids following burn injuries"</a> and  <a class="medical medical_review" href="/z/d/html/5576.html" rel="external">"Pruritus: Therapies for localized pruritus"</a> and  <a class="medical medical_review" href="/z/d/html/138411.html" rel="external">"Overview of lasers in burns and burn reconstruction"</a>.)</p><p>A variety of therapies, both systemic and topical, have been used for the treatment of post-burn pruritus. Proof of efficacy is primarily anecdotal as high-quality randomized trials have not been performed [<a href="#rid59">59,65</a>]. Systemic first-line treatment for post-burn pruritus consists of H1 and H2 antihistamines (eg, <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">diphenhydramine</a>, <a class="drug drug_general" data-topicid="9236" href="/z/d/drug information/9236.html" rel="external">cetirizine</a>, <a class="drug drug_general" data-topicid="9265" href="/z/d/drug information/9265.html" rel="external">cimetidine</a>), but none has provided complete relief. Other systemic agents that may prove helpful include <a class="drug drug_general" data-topicid="9311" href="/z/d/drug information/9311.html" rel="external">cyproheptadine</a>, <a class="drug drug_general" data-topicid="8544" href="/z/d/drug information/8544.html" rel="external">hydroxyzine</a>, <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">gabapentin</a> [<a href="#rid66">66</a>], and tricyclic antidepressants (eg, <a class="drug drug_general" data-topicid="9390" href="/z/d/drug information/9390.html" rel="external">doxepin</a>). Intravenous <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> has shown some effect in the treatment of pruritus in dermatitis [<a href="#rid67">67</a>] and treatment-resistant pruritus [<a href="#rid68">68</a>], but its potential to cause cardiac arrhythmias limits its use.</p><p>Topical treatments, which may provide relief of pruritus, include [<a href="#rid59">59,65,69-71</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Aloe vera</p><p class="bulletIndent1"><span class="glyph">●</span>Vaseline-based creams</p><p class="bulletIndent1"><span class="glyph">●</span>Cocoa butter</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10213" href="/z/d/drug information/10213.html" rel="external">Mineral oil</a></p><p class="bulletIndent1"><span class="glyph">●</span>Hydrogel sheets (eg, Tegagel, Vigilon, FlexiGel)</p><p class="bulletIndent1"><span class="glyph">●</span>Topical glucocorticoids</p><p class="bulletIndent1"><span class="glyph">●</span>Colloidal oatmeal in liquid paraffin </p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10056" href="/z/d/drug information/10056.html" rel="external">UNNA boot</a> (<a class="drug drug_general" data-topicid="8959" href="/z/d/drug information/8959.html" rel="external">glycerin</a>, <a class="drug drug_general" data-topicid="10326" href="/z/d/drug information/10326.html" rel="external">zinc oxide</a>, and <a class="drug drug_general" data-topicid="16451" href="/z/d/drug information/16451.html" rel="external">calamine lotion</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>EMLA, which is a mixture of local anesthetics</p><p class="bulletIndent1"><span class="glyph">●</span>Topical <a class="drug drug_general" data-topicid="9390" href="/z/d/drug information/9390.html" rel="external">doxepin</a></p><p class="bulletIndent1"><span class="glyph">●</span>Silicone gel sheeting</p><p class="bulletIndent1"><span class="glyph">●</span>Compression garments</p><p class="bulletIndent1"><span class="glyph">●</span>Massage therapy</p><p></p><p>The role of topical glucocorticoids (eg, <a class="drug drug_general" data-topicid="8535" href="/z/d/drug information/8535.html" rel="external">hydrocortisone</a>, <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">triamcinolone</a>) varies importantly with the stage of the burn. These agents can be applied to reepithelialized wounds. In contrast, topical glucocorticoids are <strong>not</strong> used on unhealed burns, since they can lead to thinning of the healing skin, infection, and systemic absorption. </p><p>Topical agents high in <a class="drug drug_general" data-topicid="101844" href="/z/d/drug information/101844.html" rel="external">lanolin</a> should be <strong>avoided</strong>, since they can worsen pruritus [<a href="#rid72">72</a>]. </p><p>Laser therapies have also been evaluated for the treatment of pruritus in burn patients and include pulsed dye and carbon dioxide (CO<sub>2</sub>) laser [<a href="#rid73">73-76</a>]. Although the use of lasers had been seen as largely experimental, the body of literature is growing, and their use is becoming more widespread. A systematic review on the use of CO<sub>2</sub> laser for burn scar therapy concluded that it is a safe and efficacious treatment for burn scars [<a href="#rid77">77</a>]. Specifically, there was evidence that one to four sessions of laser therapy had a positive impact on both pruritus and pain. The use of lasers in burns to manage hypertrophic scarring is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/138411.html" rel="external">"Overview of lasers in burns and burn reconstruction"</a>.)</p><p>Transcutaneous electrical nerve stimulation (TENS) remains predominantly experimental [<a href="#rid70">70,78</a>].</p><p class="headingAnchor" id="H11800906"><span class="h1">NONPHARMACOLOGIC TREATMENT OPTIONS</span><span class="headingEndMark"> — </span>Nonpharmacologic treatments should be complementary to pharmacologic approaches when treating pain, anxiety, and pruritus in the burn patient. </p><p>Empirical evidence for the efficacy of nonpharmacologic treatments has been reported with burn pain, particularly when used as an adjunct to opioid analgesics [<a href="#rid3">3</a>]. In a systematic review that included 21 randomized trials of nonpharmacologic burn pain interventions, distraction interventions, particularly virtual reality and hypnosis, reduced pain to the greatest extent [<a href="#rid79">79</a>]. However, distraction interventions may not be effective in some patients. </p><p>In choosing an approach, the team should be guided by the manner that the patient has typically responded to prior stressful medical procedures, if possible. Such responses lie on a continuum ranging from giving up control to the health care professional and desiring little information to seeking out as much information as possible and actively participating in care [<a href="#rid80">80</a>]. The following examples illustrate the types of coping styles to burn and procedural pain:</p><p class="bulletIndent1"><span class="glyph">●</span>Avoidance – Those burn patients who wish to give up control to the health care professional have a tendency toward cognitive avoidance, or an "avoidant" style of coping mechanism. They will likely use various types of distraction techniques to avoid the painful stimuli. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Approach – Those burn patients who seek out information about the procedure and attempt to participate and not relinquish control have an "approach" style of coping mechanism. These patients often find distraction techniques distressing as trying to ignore a procedure may serve to relinquish too much control. </p><p></p><p>It is important to note that both coping styles can be adaptive, and it is best for the burn care team to support an individual's coping style rather than try to change the natural response. Patients may also change their coping style depending on the procedure. As an example, a patient may find it is easier to use distraction techniques for short procedures such as receiving injections, whereas they are more comfortable attending to details of their long wound care sessions and participating when possible. Patients may also change their coping style as they become more familiar and comfortable with the environment. </p><p class="headingAnchor" id="H3133671"><span class="h2">Avoidance techniques</span><span class="headingEndMark"> — </span>Avoidance interventions are designed to psychologically distract or distance the patient from the pain. The Multiple Resource Theory of Attention suggests that diverting attention toward a nonpainful stimulus may lessen the intensity of perceived pain [<a href="#rid81">81</a>]. The four interventions in the avoidance category include distraction, guided imagery, hypnotic analgesia, and virtual reality [<a href="#rid3">3</a>]. These nonpharmacologic techniques are described below in order of those more appropriate for avoidant coping styles toward those more appropriate for the approach coping styles. However, randomized trials have not been performed to determine the optimal diversion approach as an adjunct for managing pain in burn patients.</p><p class="headingAnchor" id="H3133254"><span class="h3">Distraction</span><span class="headingEndMark"> — </span>Distraction is the most common intervention activated by patients or the provider as an adjunct for pain management in burned children [<a href="#rid82">82</a>].The types of distraction techniques available to reduce burn pain are limited only by the creativity of patients and health care professionals. Common distraction techniques used with children include bubble blowing, singing songs, reading a story, and counting. Generating distraction strategies for adults may require a bit more creativity and include engaging in enjoyable conversation during the procedure, listening to music, or playing a video game [<a href="#rid83">83-86</a>]. Gaming technology has gained more attention as evidence shows that playing an engaging, interactive video game can decrease pain during wound dressing changes, as well as physical therapy [<a href="#rid87">87-89</a>].</p><p class="headingAnchor" id="H3133268"><span class="h3">Guided imagery</span><span class="headingEndMark"> — </span>Imagery is an integrative therapy that incorporates imagined pictures, sounds, or sensations for specific therapeutic goals, such as the reduction of burn pain. While the patient is engaged in the imagery scene, less attention is available for the painful stimuli. It is the patient who selects the imagery. A related discussion on imagery and pain control in cancer patients can be found using the following link. (See  <a class="medical medical_review" href="/z/d/html/14249.html" rel="external">"Rehabilitative and integrative therapies for pain in patients with cancer", section on 'Relaxation training'</a>.)</p><p>Patients using imagery simply create or recreate an image in their mind, presumably one that they find pleasant and engaging. Prior to a painful procedure, we often have the patient elicit a "safe" or "favorite" place to go. This can be a place where they have been before (eg, a favorite vacation spot) or simply a place that they imagine to be relaxing and safe. The clinician then simply cues the patient with the details that they have provided, and we encourage them to imagine this place during their subsequent wound care. </p><p>Limited evidence suggests that guided imagery is effective in reducing the sensory and emotional components of pain [<a href="#rid90">90</a>]. The Agency for Health Care Policy and Research advocates the use of imagery for reduction of pain intensity and distress for cancer pain and for the management of mild-to-severe acute pain [<a href="#rid91">91</a>].</p><p class="headingAnchor" id="H3133302"><span class="h3">Hypnotic analgesia</span><span class="headingEndMark"> — </span>Hypnosis is an altered state of consciousness characterized by an increased receptivity to suggestion, ability to alter perceptions and sensations, and an increased capacity for dissociation [<a href="#rid92">92</a>]. It is believed that the dramatic shift in consciousness that occurs with hypnosis is the cornerstone of an individual's ability to change his/her awareness of pain [<a href="#rid93">93</a>]. Hypnotic analgesia should only be used by trained clinicians who can assess the risks and benefits of this powerful technique [<a href="#rid92">92,94</a>]. </p><p>Although hypnosis involves much more than just avoidance or distraction, the end result is often similar; the patient's focus is diverted from the pain or painful procedure. Several features make hypnotic analgesia a unique method of pain control that differs markedly from imagery or relaxation. Hypnosis may or may not lead to relaxation depending on the nature of the suggestions. In turn, it is not necessary for a patient to be relaxed or even in a deep hypnotic state in order for suggestions to be useful [<a href="#rid95">95</a>]. A related discussion on hypnotic analgesia and pain control in cancer patients can be found using the following link. (See  <a class="medical medical_review" href="/z/d/html/14249.html" rel="external">"Rehabilitative and integrative therapies for pain in patients with cancer", section on 'Clinical hypnosis'</a>.)</p><p>Hypnosis involves several stages, including building clinician-patient rapport, enhancing relaxation through deep breathing, suggestions for deepening the hypnotic state, and narrowing the patient's attention, providing posthypnotic suggestions, and alerting stage [<a href="#rid96">96</a>]. Burn patients are good candidates for hypnotic analgesia because [<a href="#rid97">97-99</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>The intense nature and severity of burn pain motivates patients to engage in hypnosis. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The behavioral regression that often occurs after a traumatic injury makes patients more willing to be taken care of by others. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with burn injuries often experience a dissociative response as a means of coping that may moderate hypnotizability. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Procedures, which cause the most intense pain, can be scheduled and thus allow hypnosis to be performed in advance of the painful stimulus.</p><p></p><p>Several studies have shown the positive effect of hypnosis when used in conjunction with prescribed analgesia [<a href="#rid99">99-103</a>]. Patients with higher baseline pain levels have a greater decrease in pain after hypnosis than patients with lower baseline pain levels. However, these studies are limited by methodological differences, lack of uniform assessment of hypnotizability and severity of pain, and small series of burn patients. One trial examined the effects of hypnosis for burn wound care in children [<a href="#rid104">104</a>]. It reported that hypnosis is effective for reducing procedural anxiety and heartrate but found no benefit for pain management. More research is needed, and the authors of the trial published their protocol for replication [<a href="#rid105">105</a>]. </p><p class="headingAnchor" id="H3133707"><span class="h3">Virtual reality</span><span class="headingEndMark"> — </span>Virtual reality diverts attention away from the painful sensations by immersing patients in a computer-generated environment [<a href="#rid3">3,106,107</a>]. Burn patients can interact with the computer while painful procedures, such as dressing changes, and range-of-motion therapy are performed. Observational and small controlled studies indicate that virtual reality is effective in reducing pain and may have utility when used in conjunction with hypnosis [<a href="#rid87">87,106,108-112</a>]. It is also becoming more widely available and user friendly [<a href="#rid113">113</a>].</p><p class="headingAnchor" id="H104704109"><span class="h2">Approach technique</span><span class="headingEndMark"> — </span>The most commonly used approach technique is information provision.</p><p class="headingAnchor" id="H810810"><span class="h3">Information provision</span><span class="headingEndMark"> — </span>Information provision, a technique that actively involves patient input, is an essential element of managing burn pain by providing treatment information in a timely and targeted manner. Information provision assists the patient's understanding of the issues, alternatives, and solutions. This process provides information on how his/her input will affect the end result, and sharing information can build trust and mutual understanding [<a href="#rid114">114</a>]. Furthermore, burn patients report a strong desire to receive additional pain education [<a href="#rid115">115</a>]. This helps to create a sense of control over one's environment. Caution should be taken to always follow a patient's lead in how much information is to be provided in that some patients who have an avoidant coping style would prefer less information, and too much information can increase anxiety.</p><p class="headingAnchor" id="H3133699"><span class="h2">Relaxation techniques</span><span class="headingEndMark"> — </span>Relaxation techniques are used to lower arousal, including unnecessary muscle tension that can increase pain [<a href="#rid3">3,116</a>]. The techniques include deep breathing exercises, progressive muscle relaxation exercises, and cognitive behavioral techniques. There are no randomized trials to determine the optimal relaxation technique to be used as an adjunct for burn pain management. </p><p class="headingAnchor" id="H3133830"><span class="h3">Deep breathing</span><span class="headingEndMark"> — </span>Deep breathing, or diaphragmatic breathing, is one of the least time-consuming techniques to employ and the easiest for adults and children to learn. When a person becomes anxious and/or experiences pain, breathing can become shallow and irregular due to the increased muscle tension in our chest wall. Such shallow breathing, known as thoracic breathing, leads to an increase in muscle tension and subsequent heightened pain [<a href="#rid116">116</a>]. </p><p>Deep breathing techniques allow patients to become aware of shallow irregular breathing and leads to relaxation that may alleviate some pain. Children can be taught bubble blowing or blowing on a pinwheel to encourage deep breathing. Adults can be taught to place a hand on their stomach and to take a breath deep enough that it passes through their chest and fills their stomach (shallow breathing is more in the chest and will not cause as much hand movement on the stomach). Their hand should rise and fall with the stomach. Exhalation is the most important part of deep breathing exercises and should not be rushed. Diaphragmatic breathing is central to all forms of relaxation and is simple and time efficient. </p><p class="headingAnchor" id="H3133838"><span class="h3">Progressive muscle relaxation</span><span class="headingEndMark"> — </span>Muscle tension increases as patients experience stress and pain; hence, the focused effort on sequentially relaxing and tensing muscles in a controlled manner diverts the attention away from the pain. Progressive muscle relaxation is a technique used to reduce anxiety associated with painful stimuli, such as burn dressing changes, by alternately tensing then relaxing muscles [<a href="#rid117">117</a>]. Muscles are sequentially tensed (10 seconds) and relaxed (20 seconds) through various parts of the body, and the technique can be performed during dressing changes. Observational studies suggest that progressive muscle relaxation can decrease recuperation time for hospitalized patients [<a href="#rid117">117</a>]. If the patient is unable to actively tense a muscle group due to pain or injury, they can still imagine each muscle becoming progressively "warm, heavy, and relaxed" or listen to a tape, a process known as autogenic training [<a href="#rid92">92</a>].</p><p class="headingAnchor" id="H3136378"><span class="h2">Cognitive behavioral techniques</span><span class="headingEndMark"> — </span>Cognitive behavioral therapy (CBT) is used to treat multiple conditions by changing thoughts and behaviors. For treatment of burn patients, CBT includes diversion, information provision, coping skills, and relaxation techniques to modify the patient's thought process about the painful experience [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/14612.html" rel="external">"Overview of psychotherapies", section on 'Cognitive and behavioral therapies'</a>.) </p><p>Expectations of a bad outcome, such as intense pain, are associated with higher levels of perceived pain [<a href="#rid118">118</a>]. This is known as catastrophizing. CBT can be used adjunctively to manage these expectations and associated pain in the following manner [<a href="#rid119">119</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Recognize that the procedure will cause pain (anticipatory pain or distress).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stop the thought that the procedure will cause pain by active efforts to reduce catastrophic thinking.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Distract from the pain by diverting attention to another thought.</p><p></p><p class="headingAnchor" id="H3075619328"><span class="h2">Mindfulness meditation</span><span class="headingEndMark"> — </span>Mindful meditation is another nonpharmacologic strategy that combines attention, cognitive restructuring, and relaxation. It has gained popularity for its effectiveness for managing acute or chronic pain in adults and adolescents [<a href="#rid120">120,121</a>]. Mindfulness involves purposeful attention on the present moment in a nonjudgmental and accepting manner [<a href="#rid122">122</a>]. Meditation refers to a broad variety of practices that are aimed at clearing the mind to self-regulate the body to achieve a state of relaxation. Several mindfulness meditation practices have been developed to address acute pain [<a href="#rid123">123,124</a>]. Although none has specifically addressed burn pain, its effectiveness in mediating procedural pain for other conditions makes it a promising intervention for acute pain during burn wound care. With the help of a trained professional, mindfulness meditation can be implemented in as little as 20 minutes prior to or during a procedure. </p><p class="headingAnchor" id="H483597553"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/117752.html" rel="external">"Society guideline links: Care of the patient with burn injury"</a>.)</p><p class="headingAnchor" id="H13088947"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Burn pain</strong> – Pain, which is present at least initially in all burn patients, varies greatly from patient to patient, shows substantial fluctuation over the hospitalization course, and can be unpredictable due to the complex interaction of anatomic, physiologic, psychosocial, and premorbid behavior. The control of burn pain and associated anxiety, as well as itching (pruritus), is challenging and demands creativity and continued staff training on pain assessment, traditional pharmacologic analgesic approaches, and adjunctive nonpharmacologic techniques. Pharmacologic analgesics should be administered by trained and experienced staff in monitored conditions. (See <a class="local">'Introduction'</a> above and <a class="local">'Characteristics of burn pain'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Burn pain assessment</strong> – Pain assessment instruments use visual and/or numeric scales to assess pain intensity, behavioral reactions, and physiologic reactions. There is no one optimal assessment technique for burn patients. The key is to choose an instrument and use it consistently. (See <a class="local">'Burn pain assessment techniques'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pharmacologic treatments</strong> – Pharmacologic agents used to treat burn pain include opioid analgesics, nonopioid analgesics, anxiolytics, and anesthetics. The type of medication used is determined by the severity of pain, the anticipated duration of pain, and intravenous (IV) access. (See <a class="local">'Pharmacologic treatment options'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Opioid analgesics</strong> – Opioid analgesics (eg, <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a>, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>), the most common type of medication used for acute pain relief, are potent and provide a dose-dependent degree of sedation important during burn wound care procedures. (See <a class="local">'Opioid analgesics'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonopioid analgesics</strong> – Nonopioid analgesics (eg, nonsteroidal anti-inflammatory drugs [NSAIDs], gabapentinoids, <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">dexmedetomidine</a>, <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a>) provide short-term, effective analgesia and sedation that may be helpful for limited burn debridement and/or dressing changes in adults and children. (See <a class="local">'Nonopioid analgesics'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Anxiolytic drugs</strong> – Anxiolytic drugs (eg, benzodiazepines) are useful in premedicating patients for wound care due to the anticipatory anxiety experienced by these patients prior to and during such procedures. (See <a class="local">'Anxiolytics'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonpharmacologic treatments</strong> – Nonpharmacologic treatments should be adjunctive to pharmacologic approaches when treating pain and anxiety in the burn patient. These approaches include cognitive distraction, information provision, relaxation, coping skills, and cognitive behavioral techniques. (See <a class="local">'Nonpharmacologic treatment options'</a> above.)</p><p></p><p class="headingAnchor" id="H1328875708"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate acknowledges Sam R Sharar, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Brown NJ, Kimble RM, Gramotnev G, et al. Predictors of re-epithelialization in pediatric burn. Burns 2014; 40:751.</a></li><li><a class="nounderline abstract_t">Askay SW, Stricklin M, Carrougher GJ, et al. Using QMethodology to identify reasons for distress in burn survivors postdischarge. J Burn Care Res 2009; 30:83.</a></li><li><a class="nounderline abstract_t">Wiechman Askay S, Patterson DR, Sharar SR, et al. Pain management in patients with burn injuries. Int Rev Psychiatry 2009; 21:522.</a></li><li><a class="nounderline abstract_t">Morgan M, Deuis JR, Frøsig-Jørgensen M, et al. Burn Pain: A Systematic and Critical Review of Epidemiology, Pathophysiology, and Treatment. Pain Med 2018; 19:708.</a></li><li><a class="nounderline abstract_t">Patterson DR, Hofland HW, Espey K, et al. Pain management. Burns 2004; 30:A10.</a></li><li><a class="nounderline abstract_t">Edwards RR, Smith MT, Klick B, et al. Symptoms of depression and anxiety as unique predictors of pain-related outcomes following burn injury. Ann Behav Med 2007; 34:313.</a></li><li><a class="nounderline abstract_t">Patterson DR, Tininenko J, Ptacek JT. Pain during burn hospitalization predicts long-term outcome. J Burn Care Res 2006; 27:719.</a></li><li><a class="nounderline abstract_t">Gamst-Jensen H, Vedel PN, Lindberg-Larsen VO, Egerod I. Acute pain management in burn patients: appraisal and thematic analysis of four clinical guidelines. Burns 2014; 40:1463.</a></li><li><a class="nounderline abstract_t">Yang HT, Hur G, Kwak IS, et al. Improvement of burn pain management through routine pain monitoring and pain management protocol. Burns 2013; 39:619.</a></li><li><a class="nounderline abstract_t">Romanowski KS, Carson J, Pape K, et al. American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps. J Burn Care Res 2020; 41:1129.</a></li><li class="breakAll">Meyer WJ, III, Wiechman SA, et al. Management of pain and other discomforts in burned patients. In: Total Burn Care, 4th ed, Herndon DN (Ed) (Ed), Saunders Elsevier, Philadelphia 2012. p.715.</li><li><a class="nounderline abstract_t">Gordon DB. Acute pain assessment tools: let us move beyond simple pain ratings. Curr Opin Anaesthesiol 2015; 28:565.</a></li><li><a class="nounderline abstract_t">Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 1997; 23:293.</a></li><li class="breakAll">Wong DL, Hockenberry-Eaton M, Wilson D, et al. Wong's Essentials of Pediatric Nursing, 6th edition, St. Louis 2001. p.1301.</li><li><a class="nounderline abstract_t">Wibbenmeyer L, Sevier A, Liao J, et al. Evaluation of the usefulness of two established pain assessment tools in a burn population. J Burn Care Res 2011; 32:52.</a></li><li><a class="nounderline abstract_t">Gaston-Johansson F, Albert M, Fagan E, Zimmerman L. Similarities in pain descriptions of four different ethnic-culture groups. J Pain Symptom Manage 1990; 5:94.</a></li><li><a class="nounderline abstract_t">Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc 2003; 4:9.</a></li><li><a class="nounderline abstract_t">Gélinas C, Johnston C. Pain assessment in the critically ill ventilated adult: validation of the Critical-Care Pain Observation Tool and physiologic indicators. Clin J Pain 2007; 23:497.</a></li><li><a class="nounderline abstract_t">Stoddard FJ, Sheridan RL, Saxe GN, et al. Treatment of pain in acutely burned children. J Burn Care Rehabil 2002; 23:135.</a></li><li><a class="nounderline abstract_t">de Jong A, Baartmans M, Bremer M, et al. Reliability, validity and clinical utility of three types of pain behavioural observation scales for young children with burns aged 0-5 years. Pain 2010; 150:561.</a></li><li><a class="nounderline abstract_t">Shen J, Giles SA, Kurtovic K, et al. Evaluation of nurse accuracy in rating procedural pain among pediatric burn patients using the Face, Legs, Activity, Cry, Consolability (FLACC) Scale. Burns 2017; 43:114.</a></li><li><a class="nounderline abstract_t">Retrouvey H, Shahrokhi S. Pain and the thermally injured patient-a review of current therapies. J Burn Care Res 2015; 36:315.</a></li><li><a class="nounderline abstract_t">Dowell D, Ragan KR, Jones CM, et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep 2022; 71:1.</a></li><li><a class="nounderline abstract_t">Hansen JK, Voss J, Ganatra H, et al. Sedation and Analgesia During Pediatric Burn Dressing Change: A Survey of American Burn Association Centers. J Burn Care Res 2019; 40:287.</a></li><li class="breakAll">Meyer WJ III, Wiechman S, Woodson L, et al. Anesthesia for burned patients. In: Total Burn Care, 4th ed, Herndon DN (Ed), Philadelpha  p.173.</li><li><a class="nounderline abstract_t">Chinchilla PA, Moyano J. Efficacy of opioids and non-opioid analgesics in the treatment of post procedure pain of burned patients: a narrative review. Braz J Anesthesiol 2022; 72:637.</a></li><li><a class="nounderline abstract_t">Nilsson A, Kalman S, Sonesson LK, et al. Difficulties in controlling mobilization pain using a standardized patient-controlled analgesia protocol in burns. J Burn Care Res 2011; 32:166.</a></li><li><a class="nounderline abstract_t">Rovers J, Knighton J, Neligan P, Peters W. Patient-controlled analgesia in burn patients: a critical review of the literature and case report. Hosp Pharm 1994; 29:106, 108.</a></li><li><a class="nounderline abstract_t">Sharar SR, Bratton SL, Carrougher GJ, et al. A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia. J Burn Care Rehabil 1998; 19:516.</a></li><li><a class="nounderline abstract_t">Sharar SR, Carrougher GJ, Selzer K, et al. A comparison of oral transmucosal fentanyl citrate and oral oxycodone for pediatric outpatient wound care. J Burn Care Rehabil 2002; 23:27.</a></li><li><a class="nounderline abstract_t">Yang C, Xu XM, He GZ. Efficacy and feasibility of opioids for burn analgesia: An evidence-based qualitative review of randomized controlled trials. Burns 2018; 44:241.</a></li><li><a class="nounderline abstract_t">Richardson P, Mustard L. The management of pain in the burns unit. Burns 2009; 35:921.</a></li><li><a class="nounderline abstract_t">Kim DE, Pruskowski KA, Ainsworth CR, et al. A Review of Adjunctive Therapies for Burn Injury Pain During the Opioid Crisis. J Burn Care Res 2019; 40:983.</a></li><li><a class="nounderline abstract_t">Wibbenmeyer L, Eid A, Liao J, et al. Gabapentin is ineffective as an analgesic adjunct in the immediate postburn period. J Burn Care Res 2014; 35:136.</a></li><li><a class="nounderline abstract_t">Gray P, Kirby J, Smith MT, et al. Pregabalin in severe burn injury pain: a double-blind, randomised placebo-controlled trial. Pain 2011; 152:1279.</a></li><li><a class="nounderline abstract_t">Lin H, Faraklas I, Sampson C, et al. Use of dexmedetomidine for sedation in critically ill mechanically ventilated pediatric burn patients. J Burn Care Res 2011; 32:98.</a></li><li><a class="nounderline abstract_t">Walker J, Maccallum M, Fischer C, et al. Sedation using dexmedetomidine in pediatric burn patients. J Burn Care Res 2006; 27:206.</a></li><li><a class="nounderline abstract_t">Asmussen S, Maybauer DM, Fraser JF, et al. A meta-analysis of analgesic and sedative effects of dexmedetomidine in burn patients. Burns 2013; 39:625.</a></li><li><a class="nounderline abstract_t">Schwenk ES, Viscusi ER, Buvanendran A, et al. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med 2018; 43:456.</a></li><li><a class="nounderline abstract_t">McGuinness SK, Wasiak J, Cleland H, et al. A systematic review of ketamine as an analgesic agent in adult burn injuries. Pain Med 2011; 12:1551.</a></li><li><a class="nounderline abstract_t">Owens VF, Palmieri TL, Comroe CM, et al. Ketamine: a safe and effective agent for painful procedures in the pediatric burn patient. J Burn Care Res 2006; 27:211.</a></li><li><a class="nounderline abstract_t">Martin-Herz SP, Patterson DR, Honari S, et al. Pediatric pain control practices of North American Burn Centers. J Burn Care Rehabil 2003; 24:26.</a></li><li><a class="nounderline abstract_t">Patterson DR, Ptacek JT, Carrougher GJ, Sharar SR. Lorazepam as an adjunct to opioid analgesics in the treatment of burn pain. Pain 1997; 72:367.</a></li><li class="breakAll">US Food and Drug Administration. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or.</li><li><a class="nounderline abstract_t">Aleo E, Picado AL, Abancens BJ, et al. Evaluation of the Effect of Hydroxyzine on Preoperative Anxiety and Anesthetic Adequacy in Children: Double Blind Randomized Clinical Trial. Biomed Res Int 2021; 2021:7394042.</a></li><li><a class="nounderline abstract_t">Bittner EA, Shank E, Woodson L, Martyn JA. Acute and perioperative care of the burn-injured patient. Anesthesiology 2015; 122:448.</a></li><li><a class="nounderline abstract_t">Han TH, Greenblatt DJ, Martyn JA. Propofol clearance and volume of distribution are increased in patients with major burns. J Clin Pharmacol 2009; 49:768.</a></li><li><a class="nounderline abstract_t">Yuxiang L, Lu T, Jianqiang Y, et al. Analgesia effect of a fixed nitrous oxide/oxygen mixture on burn dressing pain: study protocol for a randomized controlled trial. Trials 2012; 13:67.</a></li><li><a class="nounderline abstract_t">Dimick P, Helvig E, Heimbach D, et al. Anesthesia-assisted procedures in a burn intensive care unit procedure room: benefits and complications. J Burn Care Rehabil 1993; 14:446.</a></li><li><a class="nounderline abstract_t">Powers PS, Cruse CW, Daniels S, Stevens BA. Safety and efficacy of debridement under anesthesia in patients with burns. J Burn Care Rehabil 1993; 14:176.</a></li><li><a class="nounderline abstract_t">Town CJ, Johnson J, Van Zundert A, Strand H. Exploring the Role of Regional Anesthesia in the Treatment of the Burn-injured Patient: A Narrative Review of Current Literature. Clin J Pain 2019; 35:368.</a></li><li><a class="nounderline abstract_t">Shank ES, Martyn JA, Donelan MB, et al. Ultrasound-Guided Regional Anesthesia for Pediatric Burn Reconstructive Surgery: A Prospective Study. J Burn Care Res 2016; 37:e213.</a></li><li><a class="nounderline abstract_t">Cuignet O, Pirson J, Boughrouph J, Duville D. The efficacy of continuous fascia iliaca compartment block for pain management in burn patients undergoing skin grafting procedures. Anesth Analg 2004; 98:1077.</a></li><li><a class="nounderline abstract_t">Cuignet O, Mbuyamba J, Pirson J. The long-term analgesic efficacy of a single-shot fascia iliaca compartment block in burn patients undergoing skin-grafting procedures. J Burn Care Rehabil 2005; 26:409.</a></li><li><a class="nounderline abstract_t">Shteynberg A, Riina LH, Glickman LT, et al. Ultrasound guided lateral femoral cutaneous nerve (LFCN) block: safe and simple anesthesia for harvesting skin grafts. Burns 2013; 39:146.</a></li><li><a class="nounderline abstract_t">Sheckter CC, Stewart BT, Barnes C, et al. Techniques and strategies for regional anesthesia in acute burn care-a narrative review. Burns Trauma 2021; 9:tkab015.</a></li><li><a class="nounderline abstract_t">Punja K, Graham M, Cartotto R. Continuous infusion of epidural morphine in frostbite. J Burn Care Rehabil 1998; 19:142.</a></li><li><a class="nounderline abstract_t">Still JM, Abramson R, Law EJ. Development of an epidural abscess following staphylococcal septicemia in an acutely burned patient: case report. J Trauma 1995; 38:958.</a></li><li><a class="nounderline abstract_t">Goutos I, Dziewulski P, Richardson PM. Pruritus in burns: review article. J Burn Care Res 2009; 30:221.</a></li><li><a class="nounderline abstract_t">O'Donoghue M, Tharp MD. Antihistamines and their role as antipruritics. Dermatol Ther 2005; 18:333.</a></li><li><a class="nounderline abstract_t">Van Loey NE, Bremer M, Faber AW, et al. Itching following burns: epidemiology and predictors. Br J Dermatol 2008; 158:95.</a></li><li><a class="nounderline abstract_t">McGarry S, Burrows S, Ashoorian T, et al. Mental health and itch in burns patients: Potential associations. Burns 2016; 42:763.</a></li><li><a class="nounderline abstract_t">Nedelec B, Carrougher GJ. Pain and Pruritus Postburn Injury. J Burn Care Res 2017; 38:142.</a></li><li><a class="nounderline abstract_t">Carrougher GJ, Martinez EM, McMullen KS, et al. Pruritus in adult burn survivors: postburn prevalence and risk factors associated with increased intensity. J Burn Care Res 2013; 34:94.</a></li><li><a class="nounderline abstract_t">Bell PL, Gabriel V. Evidence based review for the treatment of post-burn pruritus. J Burn Care Res 2009; 30:55.</a></li><li><a class="nounderline abstract_t">McGovern C, Quasim T, Puxty K, et al. Neuropathic agents in the management of pruritus in burn injuries: a systematic review and meta-analysis. Trauma Surg Acute Care Open 2021; 6:e000810.</a></li><li><a class="nounderline abstract_t">Sun PY, Li HG, Xu QY, et al. Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons. Br J Pharmacol 2023; 180:1339.</a></li><li><a class="nounderline abstract_t">Fishman SM, Caneris OA, Stojanovic MP, Borsook D. Intravenous lidocaine for treatment-resistant pruritus. Am J Med 1997; 102:584.</a></li><li class="breakAll">Hartford CE, Kealey GP. Care of outpatient burns. In: Total Burn Care, Third edition, Herndon, DN (Eds), 2007. p.67.</li><li><a class="nounderline abstract_t">Whitaker C. The use of TENS for pruritus relief in the burns patient: an individual case report. J Burn Care Rehabil 2001; 22:274.</a></li><li><a class="nounderline abstract_t">Li-Tsang CW, Lau JC, Choi J, et al. A prospective randomized clinical trial to investigate the effect of silicone gel sheeting (Cica-Care) on post-traumatic hypertrophic scar among the Chinese population. Burns 2006; 32:678.</a></li><li><a class="nounderline abstract_t">Baxter CR. Management of burn wounds. Dermatol Clin 1993; 11:709.</a></li><li><a class="nounderline abstract_t">Allison KP, Kiernan MN, Waters RA, Clement RM. Pulsed dye laser treatment of burn scars. Alleviation or irritation? Burns 2003; 29:207.</a></li><li><a class="nounderline abstract_t">Parrett BM, Donelan MB. Pulsed dye laser in burn scars: current concepts and future directions. Burns 2010; 36:443.</a></li><li><a class="nounderline abstract_t">Kono T, Erçöçen AR, Nakazawa H, Nozaki M. Treatment of hypertrophic scars using a long-pulsed dye laser with cryogen-spray cooling. Ann Plast Surg 2005; 54:487.</a></li><li><a class="nounderline abstract_t">Alster TS, Nanni CA. Pulsed dye laser treatment of hypertrophic burn scars. Plast Reconstr Surg 1998; 102:2190.</a></li><li><a class="nounderline abstract_t">Choi KJ, Williams EA, Pham CH, et al. Fractional CO2 laser treatment for burn scar improvement: A systematic review and meta-analysis. Burns 2021; 47:259.</a></li><li><a class="nounderline abstract_t">Hettrick HH, O'Brien K, Laznick H, et al. Effect of transcutaneous electrical nerve stimulation for the management of burn pruritus: a pilot study. J Burn Care Rehabil 2004; 25:236.</a></li><li><a class="nounderline abstract_t">Scheffler M, Koranyi S, Meissner W, et al. Efficacy of non-pharmacological interventions for procedural pain relief in adults undergoing burn wound care: A systematic review and meta-analysis of randomized controlled trials. Burns 2018; 44:1709.</a></li><li><a class="nounderline abstract_t">Martin-Herz SP, Thurber CA, Patterson DR. Psychological principles of burn wound pain in children. II: Treatment applications. J Burn Care Rehabil 2000; 21:458.</a></li><li><a class="nounderline abstract_t">Wickens CD, Helleberg J, Xu X. Pilot maneuver choice and workload in free flight. Hum Factors 2002; 44:171.</a></li><li><a class="nounderline abstract_t">Hanson MD, Gauld M, Wathen CN, Macmillan HL. Nonpharmacological interventions for acute wound care distress in pediatric patients with burn injury: a systematic review. J Burn Care Res 2008; 29:730.</a></li><li><a class="nounderline abstract_t">Parker M, Delahunty B, Heberlein N, et al. Interactive gaming consoles reduced pain during acute minor burn rehabilitation: A randomized, pilot trial. Burns 2016; 42:91.</a></li><li><a class="nounderline abstract_t">Hsu KC, Chen LF, Hsiep PH. Effect of music intervention on burn patients' pain and anxiety during dressing changes. Burns 2016; 42:1789.</a></li><li><a class="nounderline abstract_t">Najafi Ghezeljeh T, Mohades Ardebili F, Rafii F. The effects of massage and music on pain, anxiety and relaxation in burn patients: Randomized controlled clinical trial. Burns 2017; 43:1034.</a></li><li><a class="nounderline abstract_t">Landolt MA, Marti D, Widmer J, Meuli M. Does cartoon movie distraction decrease burned children's pain behavior? J Burn Care Rehabil 2002; 23:61.</a></li><li><a class="nounderline abstract_t">Kipping B, Rodger S, Miller K, Kimble RM. Virtual reality for acute pain reduction in adolescents undergoing burn wound care: a prospective randomized controlled trial. Burns 2012; 38:650.</a></li><li><a class="nounderline abstract_t">Parry I, Painting L, Bagley A, et al. A Pilot Prospective Randomized Control Trial Comparing Exercises Using Videogame Therapy to Standard Physical Therapy: 6 Months Follow-Up. J Burn Care Res 2015; 36:534.</a></li><li><a class="nounderline abstract_t">Miller K, Rodger S, Kipping B, Kimble RM. A novel technology approach to pain management in children with burns: A prospective randomized controlled trial. Burns 2011; 37:395.</a></li><li><a class="nounderline abstract_t">Eller LS. Guided imagery interventions for symptom management. Annu Rev Nurs Res 1999; 17:57.</a></li><li><a class="nounderline abstract_t">Acute pain management: operative or medical procedures and trauma, Part 2. Agency for Health Care Policy and Research. Clin Pharm 1992; 11:391.</a></li><li class="breakAll">Patterson DR. Clinical hypnosis for pain control. American Psychological Association: Washington, DC, US. 2010. page 37.doi: 10.1037/12128-002. psycnet.apa.org/books/12128/ (Accessed on June 13, 2011).</li><li class="breakAll">Barber J. A brief introduction to hypnotic analgesia. In: Hypnosis and Suggestion in the Treatment of Pain, Barber J (Ed), WW Norton &amp; Company, New York 1996. p.3.</li><li><a class="nounderline abstract_t">Barber J. Rapid induction analgesia: a clinical report. Am J Clin Hypn 1977; 19:138.</a></li><li><a class="nounderline abstract_t">Wark DM. Alert hypnosis: a review and case report. Am J Clin Hypn 2006; 48:291.</a></li><li class="breakAll">Patterson DR. Burn Pain. In: Hypnosis and Suggestion in the Treatment of Pain, Barber J (Ed), WW Norton &amp; Company, New York 1996. p.267.</li><li><a class="nounderline abstract_t">Patterson DR, Adcock RJ, Bombardier CH. Factors predicting hypnotic analgesia in clinical burn pain. Int J Clin Exp Hypn 1997; 45:377.</a></li><li><a class="nounderline abstract_t">Patterson DR, Ptacek JT. Baseline pain as a moderator of hypnotic analgesia for burn injury treatment. J Consult Clin Psychol 1997; 65:60.</a></li><li><a class="nounderline abstract_t">Wiechman Askay S, Patterson DR, Jensen MP, Sharar SR. A randomized controlled trial of hypnosis for burn wound care. Rehabilitation Psychology 2007; 52:247.</a></li><li><a class="nounderline abstract_t">Montgomery GH, DuHamel KN, Redd WH. A meta-analysis of hypnotically induced analgesia: how effective is hypnosis? Int J Clin Exp Hypn 2000; 48:138.</a></li><li><a class="nounderline abstract_t">Patterson DR, Jensen MP. Hypnosis and clinical pain. Psychol Bull 2003; 129:495.</a></li><li><a class="nounderline abstract_t">Patterson DR, Questad KA, Boltwood MD, et al. Patient self-reports three months after sustaining a major burn. J Burn Care Rehabil 1987; 8:274.</a></li><li><a class="nounderline abstract_t">Wakeman JR, Kaplan JZ. An experimental study of hypnosis in painful burns. Am J Clin Hypn 1978; 21:3.</a></li><li><a class="nounderline abstract_t">Chester SJ, Tyack Z, De Young A, et al. Efficacy of hypnosis on pain, wound-healing, anxiety, and stress in children with acute burn injuries: a randomized controlled trial. Pain 2018; 159:1790.</a></li><li><a class="nounderline abstract_t">Chester SJ, Stockton K, De Young A, et al. Effectiveness of medical hypnosis for pain reduction and faster wound healing in pediatric acute burn injury: study protocol for a randomized controlled trial. Trials 2016; 17:223.</a></li><li><a class="nounderline abstract_t">Patterson DR, Tininenko JR, Schmidt AE, Sharar SR. Virtual reality hypnosis: a case report. Int J Clin Exp Hypn 2004; 52:27.</a></li><li><a class="nounderline abstract_t">McSherry T, Atterbury M, Gartner S, et al. Randomized, Crossover Study of Immersive Virtual Reality to Decrease Opioid Use During Painful Wound Care Procedures in Adults. J Burn Care Res 2018; 39:278.</a></li><li><a class="nounderline abstract_t">Czech O, Wrzeciono A, Batalík L, et al. Virtual reality intervention as a support method during wound care and rehabilitation after burns: A systematic review and meta-analysis. Complement Ther Med 2022; 68:102837.</a></li><li><a class="nounderline abstract_t">Hoffman HG, Patterson DR, Carrougher GJ. Use of virtual reality for adjunctive treatment of adult burn pain during physical therapy: a controlled study. Clin J Pain 2000; 16:244.</a></li><li><a class="nounderline abstract_t">Patterson DR, Wiechman SA, Jensen M, Sharar SR. Hypnosis delivered through immersive virtual reality for burn pain: A clinical case series. Int J Clin Exp Hypn 2006; 54:130.</a></li><li><a class="nounderline abstract_t">Sharar SR, Miller W, Teeley A, et al. Applications of virtual reality for pain management in burn-injured patients. Expert Rev Neurother 2008; 8:1667.</a></li><li><a class="nounderline abstract_t">Faber AW, Patterson DR, Bremer M. Repeated use of immersive virtual reality therapy to control pain during wound dressing changes in pediatric and adult burn patients. J Burn Care Res 2013; 34:563.</a></li><li><a class="nounderline abstract_t">Furness PJ, Phelan I, Babiker NT, et al. Reducing Pain During Wound Dressings in Burn Care Using Virtual Reality: A Study of Perceived Impact and Usability With Patients and Nurses. J Burn Care Res 2019; 40:878.</a></li><li class="breakAll">Burn pain: Nonpharmacologic approaches. Pain ladder treating pain painladder.com/index.php/acute-pain/burn-pain-nonpharmacologic-approaches (Accessed on June 22, 2011).</li><li><a class="nounderline abstract_t">Duchin ER, Moore M, Carrougher GJ, et al. Burn patients' pain experiences and perceptions. Burns 2021; 47:1627.</a></li><li class="breakAll">Greenberg JS. Part 3. General applications: Relaxation techniques.  Chapter 10. Autogenic training, imagery, and progressive relaxation. In: Comprehensive Stress Management, 12th, Greenberg JS (Ed), McGraw-Hill Higher Education, New York 2011. p.203.</li><li class="breakAll">Jacobson E. Progressive Relaxation, University of Chicago Press, Chicago 1938.</li><li><a class="nounderline abstract_t">Edwards RR, Haythornthwaite JA, Sullivan MJ, Fillingim RB. Catastrophizing as a mediator of sex differences in pain: differential effects for daily pain versus laboratory-induced pain. Pain 2004; 111:335.</a></li><li><a class="nounderline abstract_t">Thurber CA, Martin-Herz SP, Patterson DR. Psychological principles of burn wound pain in children. I: theoretical framework. J Burn Care Rehabil 2000; 21:376.</a></li><li><a class="nounderline abstract_t">Zeidan F, Gordon NS, Merchant J, Goolkasian P. The effects of brief mindfulness meditation training on experimentally induced pain. J Pain 2010; 11:199.</a></li><li><a class="nounderline abstract_t">Petter M, Chambers CT, McGrath PJ, Dick BD. The role of trait mindfulness in the pain experience of adolescents. J Pain 2013; 14:1709.</a></li><li class="breakAll">Kabat-Zinn J. Full catastrophe living: How to cope with stress pain and illness using mindfulness meditation, Piatkus, London 1996.</li><li><a class="nounderline abstract_t">Fanurik D, Zeltzer LK, Roberts MC, Blount RL. The relationship between children's coping styles and psychological interventions for cold pressor pain. Pain 1993; 53:213.</a></li><li><a class="nounderline abstract_t">Williams H, Simmons LA, Tanabe P. Mindfulness-Based Stress Reduction in Advanced Nursing Practice: A Nonpharmacologic Approach to Health Promotion, Chronic Disease Management, and Symptom Control. J Holist Nurs 2015; 33:247.</a></li></ol></div><div id="topicVersionRevision">Topic 14989 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24184285" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Predictors of re-epithelialization in pediatric burn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19060733" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Using QMethodology to identify reasons for distress in burn survivors postdischarge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19919205" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Pain management in patients with burn injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29036469" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Burn Pain: A Systematic and Critical Review of Epidemiology, Pathophysiology, and Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15555783" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pain management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18020941" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Symptoms of depression and anxiety as unique predictors of pain-related outcomes following burn injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16998406" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pain during burn hospitalization predicts long-term outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25277698" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Acute pain management in burn patients: appraisal and thematic analysis of four clinical guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23182650" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Improvement of burn pain management through routine pain monitoring and pain management protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32885244" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32885244" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26237235" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Acute pain assessment tools: let us move beyond simple pain ratings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9220806" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The FLACC: a behavioral scale for scoring postoperative pain in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9220806" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The FLACC: a behavioral scale for scoring postoperative pain in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21116190" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Evaluation of the usefulness of two established pain assessment tools in a burn population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2348093" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Similarities in pain descriptions of four different ethnic-culture groups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12807591" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17575489" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Pain assessment in the critically ill ventilated adult: validation of the Critical-Care Pain Observation Tool and physiologic indicators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11882804" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Treatment of pain in acutely burned children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20619968" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Reliability, validity and clinical utility of three types of pain behavioural observation scales for young children with burns aged 0-5 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27576937" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Evaluation of nurse accuracy in rating procedural pain among pediatric burn patients using the Face, Legs, Activity, Cry, Consolability (FLACC) Scale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24823343" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pain and the thermally injured patient-a review of current therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36327391" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30844056" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Sedation and Analgesia During Pediatric Burn Dressing Change: A Survey of American Burn Association Centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30844056" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Sedation and Analgesia During Pediatric Burn Dressing Change: A Survey of American Burn Association Centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34364900" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Efficacy of opioids and non-opioid analgesics in the treatment of post procedure pain of burned patients: a narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21116189" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Difficulties in controlling mobilization pain using a standardized patient-controlled analgesia protocol in burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10132149" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Patient-controlled analgesia in burn patients: a critical review of the literature and case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9848042" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11803309" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A comparison of oral transmucosal fentanyl citrate and oral oxycodone for pediatric outpatient wound care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29169696" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Efficacy and feasibility of opioids for burn analgesia: An evidence-based qualitative review of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19505764" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The management of pain in the burns unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31259369" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : A Review of Adjunctive Therapies for Burn Injury Pain During the Opioid Crisis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23511293" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Gabapentin is ineffective as an analgesic adjunct in the immediate postburn period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21398038" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pregabalin in severe burn injury pain: a double-blind, randomised placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21088616" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Use of dexmedetomidine for sedation in critically ill mechanically ventilated pediatric burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16566567" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Sedation using dexmedetomidine in pediatric burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23465796" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A meta-analysis of analgesic and sedative effects of dexmedetomidine in burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29870457" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21880111" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A systematic review of ketamine as an analgesic agent in adult burn injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16566568" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Ketamine: a safe and effective agent for painful procedures in the pediatric burn patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12543988" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Pediatric pain control practices of North American Burn Centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9313277" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Lorazepam as an adjunct to opioid analgesics in the treatment of burn pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9313277" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Lorazepam as an adjunct to opioid analgesics in the treatment of burn pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34805403" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Evaluation of the Effect of Hydroxyzine on Preoperative Anxiety and Anesthetic Adequacy in Children: Double Blind Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25485468" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Acute and perioperative care of the burn-injured patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19553403" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Propofol clearance and volume of distribution are increased in patients with major burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22624697" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Analgesia effect of a fixed nitrous oxide/oxygen mixture on burn dressing pain: study protocol for a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8408170" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Anesthesia-assisted procedures in a burn intensive care unit procedure room: benefits and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8501106" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Safety and efficacy of debridement under anesthesia in patients with burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30540588" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Exploring the Role of Regional Anesthesia in the Treatment of the Burn-injured Patient: A Narrative Review of Current Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25412051" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Ultrasound-Guided Regional Anesthesia for Pediatric Burn Reconstructive Surgery: A Prospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15041602" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : The efficacy of continuous fascia iliaca compartment block for pain management in burn patients undergoing skin grafting procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16151286" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The long-term analgesic efficacy of a single-shot fascia iliaca compartment block in burn patients undergoing skin-grafting procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22657583" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Ultrasound guided lateral femoral cutaneous nerve (LFCN) block: safe and simple anesthesia for harvesting skin grafts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34285927" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Techniques and strategies for regional anesthesia in acute burn care-a narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9556318" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Continuous infusion of epidural morphine in frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7602646" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Development of an epidural abscess following staphylococcal septicemia in an acutely burned patient: case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19165110" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Pruritus in burns: review article.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16297006" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Antihistamines and their role as antipruritics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17986307" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Itching following burns: epidemiology and predictors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26948956" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Mental health and itch in burns patients: Potential associations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28328657" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Pain and Pruritus Postburn Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23079565" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Pruritus in adult burn survivors: postburn prevalence and risk factors associated with increased intensity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19060768" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Evidence based review for the treatment of post-burn pruritus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34722931" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Neuropathic agents in the management of pruritus in burn injuries: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36521846" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9217675" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Intravenous lidocaine for treatment-resistant pruritus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9217675" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Intravenous lidocaine for treatment-resistant pruritus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11482686" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : The use of TENS for pruritus relief in the burns patient: an individual case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16837136" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A prospective randomized clinical trial to investigate the effect of silicone gel sheeting (Cica-Care) on post-traumatic hypertrophic scar among the Chinese population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8222354" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Management of burn wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12706612" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Pulsed dye laser treatment of burn scars. Alleviation or irritation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20022430" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Pulsed dye laser in burn scars: current concepts and future directions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15838209" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Treatment of hypertrophic scars using a long-pulsed dye laser with cryogen-spray cooling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9811021" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Pulsed dye laser treatment of hypertrophic burn scars.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33288326" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Fractional CO2 laser treatment for burn scar improvement: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15273463" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Effect of transcutaneous electrical nerve stimulation for the management of burn pruritus: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29287729" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Efficacy of non-pharmacological interventions for procedural pain relief in adults undergoing burn wound care: A systematic review and meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11020055" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Psychological principles of burn wound pain in children. II: Treatment applications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12452266" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Pilot maneuver choice and workload in free flight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18695617" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Nonpharmacological interventions for acute wound care distress in pediatric patients with burn injury: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26546386" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Interactive gaming consoles reduced pain during acute minor burn rehabilitation: A randomized, pilot trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27263418" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Effect of music intervention on burn patients' pain and anxiety during dressing changes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28169080" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : The effects of massage and music on pain, anxiety and relaxation in burn patients: Randomized controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11803316" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Does cartoon movie distraction decrease burned children's pain behavior?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22348801" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Virtual reality for acute pain reduction in adolescents undergoing burn wound care: a prospective randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26335108" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : A Pilot Prospective Randomized Control Trial Comparing Exercises Using Videogame Therapy to Standard Physical Therapy: 6 Months Follow-Up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21306828" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : A novel technology approach to pain management in children with burns: A prospective randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10418653" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Guided imagery interventions for symptom management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1582131" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Acute pain management: operative or medical procedures and trauma, Part 2. Agency for Health Care Policy and Research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1582131" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Acute pain management: operative or medical procedures and trauma, Part 2. Agency for Health Care Policy and Research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1582131" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Acute pain management: operative or medical procedures and trauma, Part 2. Agency for Health Care Policy and Research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/835486" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Rapid induction analgesia: a clinical report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16696560" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Alert hypnosis: a review and case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16696560" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Alert hypnosis: a review and case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9308266" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Factors predicting hypnotic analgesia in clinical burn pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9103735" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Baseline pain as a moderator of hypnotic analgesia for burn injury treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : A randomized controlled trial of hypnosis for burn wound care</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10769981" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : A meta-analysis of hypnotically induced analgesia: how effective is hypnosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12848218" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Hypnosis and clinical pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3654716" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Patient self-reports three months after sustaining a major burn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/696661" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : An experimental study of hypnosis in painful burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29939959" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Efficacy of hypnosis on pain, wound-healing, anxiety, and stress in children with acute burn injuries: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27129580" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Effectiveness of medical hypnosis for pain reduction and faster wound healing in pediatric acute burn injury: study protocol for a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14768967" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Virtual reality hypnosis: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28570305" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Randomized, Crossover Study of Immersive Virtual Reality to Decrease Opioid Use During Painful Wound Care Procedures in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35490982" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Virtual reality intervention as a support method during wound care and rehabilitation after burns: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11014398" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Use of virtual reality for adjunctive treatment of adult burn pain during physical therapy: a controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16581687" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Hypnosis delivered through immersive virtual reality for burn pain: A clinical case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18986237" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Applications of virtual reality for pain management in burn-injured patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23970314" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Repeated use of immersive virtual reality therapy to control pain during wound dressing changes in pediatric and adult burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31190052" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Reducing Pain During Wound Dressings in Burn Care Using Virtual Reality: A Study of Perceived Impact and Usability With Patients and Nurses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31190052" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Reducing Pain During Wound Dressings in Burn Care Using Virtual Reality: A Study of Perceived Impact and Usability With Patients and Nurses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33642121" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Burn patients' pain experiences and perceptions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33642121" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Burn patients' pain experiences and perceptions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33642121" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Burn patients' pain experiences and perceptions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15363877" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Catastrophizing as a mediator of sex differences in pain: differential effects for daily pain versus laboratory-induced pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10935822" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Psychological principles of burn wound pain in children. I: theoretical framework.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19853530" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : The effects of brief mindfulness meditation training on experimentally induced pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24290451" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : The role of trait mindfulness in the pain experience of adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24290451" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : The role of trait mindfulness in the pain experience of adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8336991" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : The relationship between children's coping styles and psychological interventions for cold pressor pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25673578" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Mindfulness-Based Stress Reduction in Advanced Nursing Practice: A Nonpharmacologic Approach to Health Promotion, Chronic Disease Management, and Symptom Control.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
